Masuoka K. Lorianne
SVP & Chief Medical Officer, Nektar Therapeutics.
Companies
- DiaMedica Therapeutics Inc.Chief Medical Officer Jan 23, 2024 to Jan 23, 20241
- OPIANT PHARMACEUTICALS, INC.Board member Mar 22, 2021 to Mar 3, 20232
- Marinus Pharmaceuticals (United States)Chief Medical Officer May 15, 2017 to Aug 23, 20193
- INVIVO THERAPEUTICS HOLDINGS CORP.Chief Medical Officer Mar 4, 2015 to Jan 22, 20164
- Nektar TherapeuticsSVP & Chief Medical Officer Dec 4, 2009 to Feb 10, 20115
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OPIANT PHARMACEUTICALS, INC.0 shares6Mar 2, 2023
- DiaMedica Therapeutics Inc. DMAC0 shares7Jan 23, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023Returned to company 2,000 shares at $20.00 of OPIANT PHARMACEUTICALS, INC.6
- Mar 2, 2023Returned to company 2,000 shares at $20.00 of OPIANT PHARMACEUTICALS, INC.6
- Jun 14, 2022Granted 2,000 shares of OPIANT PHARMACEUTICALS, INC.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 14, 2022